Management tracks: Gottlieb joins Pfizer board; plus Adaptimmune, Xencor, Arcus and more

Pfizer Inc. (NYSE:PFE) appointed former FDA Commissioner Scott Gottlieb to its board. Gottlieb is joining the board's regulatory and compliance and science and technology committees. Since leaving the FDA in early April, Gottlieb returned to New Enterprise Associates as special partner and to the American Enterprise Institute as a fellow.

CFO Adrian Rawcliffe will succeed James Noble as CEO of Adaptimmune Therapeutics plc (NASDAQ:ADAP), effective Sept. 1. Noble, who is retiring, will join the T cell therapy company’s board. The company has begun a search for a new CFO...